In this regard, in RA patients treated with anti-TNF therapy, LEAP2 levels correlated positively with other inflammatory parameters, such as IL6, IL-8, MCP-1, and LCN2, suggesting that inflammatory status is crucial to the modulation of LEAP2. This evidence concerns the gene LCN2 and rheumatoid arthritis.